Deep Vein Thrombosis
2 competing products in clinical development for Deep Vein Thrombosis.
Pipeline by Phase
Phase 11
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| edoxaban tosylate + enoxaparin/unfractionated heparin + warfarin | Daiichi Sankyo | Phase 2 | Completed | 35 |
| Edoxaban low dose + Edoxaban high dose | Daiichi Sankyo | Phase 1 | Completed | 29 |